{"id":292,"date":"2021-03-08T21:29:54","date_gmt":"2021-03-08T21:29:54","guid":{"rendered":"https:\/\/www.radxrad.org\/?post_type=resource&#038;p=292"},"modified":"2021-12-03T13:25:18","modified_gmt":"2021-12-03T21:25:18","slug":"fda-policy-for-evaluating-impact-of-viral-mutations-on-covid-19-tests","status":"publish","type":"resource","link":"https:\/\/www.radxrad.org\/resource\/fda-policy-for-evaluating-impact-of-viral-mutations-on-covid-19-tests\/","title":{"rendered":"FDA Policy for Evaluating Impact of Viral Mutations on COVID-19 Tests"},"content":{"rendered":"\r\n<p>Up-to-date Variant guidance from the FDA<\/p>\r\n","protected":false},"author":2,"menu_order":0,"template":"","meta":{"inline_featured_image":false},"resource_cat":[68,7],"class_list":["post-292","resource","type-resource","status-publish","hentry","resource_cat-diagnostic-core-resources","resource_cat-policy"],"acf":[],"_links":{"self":[{"href":"https:\/\/www.radxrad.org\/wp-json\/wp\/v2\/resource\/292","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.radxrad.org\/wp-json\/wp\/v2\/resource"}],"about":[{"href":"https:\/\/www.radxrad.org\/wp-json\/wp\/v2\/types\/resource"}],"author":[{"embeddable":true,"href":"https:\/\/www.radxrad.org\/wp-json\/wp\/v2\/users\/2"}],"wp:attachment":[{"href":"https:\/\/www.radxrad.org\/wp-json\/wp\/v2\/media?parent=292"}],"wp:term":[{"taxonomy":"resource_cat","embeddable":true,"href":"https:\/\/www.radxrad.org\/wp-json\/wp\/v2\/resource_cat?post=292"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}